Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
An Ebola vaccine developed by Glaxosmithkline (GSK) has passed its first phase trial after testing 20 volunteers in the US. The British drugmaker said the vaccine was "well-tolerated" and produced an immunological response in all the volunteers. The vaccine, produced by the National Institutes of H
Read moreThe UK stock market opened flat on Thursday as investors awaited a jam-packed day full of economic data, policymaker speeches and a pivotal meeting of the Organization of Petroleum Exporting Countries (OPEC). London's FTSE 100 index was down 0.1% at 6,722 in early deals. While US markets will be cl
Read moreUS markets might be closed together for Thanksgiving but those hoping for a quiet day could be disappointed with the Organization of Petroleum Exporting Countries (OPEC) set for a pivotal meeting in Vienna. City sources predict the FTSE 100 will open around eight points higher than yesterday's close
Read more
NEW YORK, Nov 26 (Reuters) - An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
Read more(Adds approval of GlaxoSmithKline deals with Novartis) WASHINGTON, Nov 26 (Reuters) - U.S. antitrust regulators on
Wednesday approved a pair of major deals in the medical field,
including Medtronic's purchase of Covidien, which will allow it
to take advantage of tax breaks in Ireland.
WASHINGTON, Nov 26 (Reuters) - GlaxoSmithKline won U.S. antitrust approval to buy Novartis AG's vaccine business, with the exception of influenza vaccines, the two companies said on Wednesday. The deal is part of a three-way transaction unveiled in April, which includes Britain's GSK buying
Read more(Adds background on deal, Novartis statement) WASHINGTON, Nov 26 (Reuters) - Switzerland's Novartis AG has agreed to sell its nicotine patch, Habitrol, in order to win U.S. antitrust approval for a consumer healthcare joint venture with Britain's GlaxoSmithKline, the U.S. Federal Trade Com
Read moreWASHINGTON, Nov 26 (Reuters) - Novartis AG has agreed to sell its nicotine patch, Habitrol, in order to win U.S. antitrust approval for a consumer healthcare joint venture with Britain's GlaxoSmithKline, the U.S. Federal Trade Commission said on Wednesday. Novartis and GlaxoSmithKline had
Read more** Pfizer can resume its pursuit of AstraZeneca from today as 6-month cooling-off period ends but chances of a fresh bid seen as slim, especially after the U.S. drugmaker's big oncology deal with Merck KGaA last week. ** Jefferies analysts reckon Mylan, which is buying some of Abbott's esta
Read more(Adds terms of deal, details on WHO-coordinated trials; updates share movement) By Ransdell Pierson Nov 24 (Reuters) - Merck & Co Inc on Monday said it would buy worldwide commercial rights to NewLink Genetics Corp's experimental vaccine against the Ebola virus. NewLink, whose
Read moreLONDON, Nov 24 (Reuters) - Britain's GlaxoSmithKline has asked its shareholders to vote at a meeting on Dec. 18 on its proposed major deal with Switzerland's Novartis, which will see the two pharmaceutical group trade more than $20 billion of assets. The transaction, which includes GSK buy
Read more* Innovative Medicines and MedTech Review to report in 2015 * Follows criticism that Britain is too slow to adopt new drugs * Britain eager to promote itself as life-science hub * Merck, Becton Dickinson plan 63 mln stg investment LONDON, Nov 20 (Reuters) - The British gov
Read moreGENEVA, Nov 19 (Reuters) - A Cuban doctor infected with Ebola in Sierra Leone will be flown to Switzerland in the next 48 hours for hospitalisation in Geneva, Swiss health authorities said on Wednesday. The doctor, identified by Cuba's official website Cubadebate on Tuesday as Felix Baez, i
Read moreLONDON, Nov 17 (Reuters) - An experimental lupus drug from AstraZeneca significantly improved the symptoms of lupus in a mid-stage clinical trial, boosting prospects for a medicine the company believes could become a major seller. Only one new drug -- GlaxoSmithKline's Benlysta -- has been
Read moreBy Kate Kelland LONDON, Nov 17 (Reuters) - Almost 200 people have received GlaxoSmithKline's experimental Ebola vaccine in trials in the United States, Britain, Mali and Switzerland, and the safety data so far are "very satisfactory", scientists said on Monday. The trials, which began
Read more
Last checked at